Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intellia Therapeutics (NTLA) Non Operating Investment Income: 2019-2025

Historic Non Operating Investment Income for Intellia Therapeutics (NTLA) over the last 7 years, with Sep 2025 value amounting to $3.4 million.

  • Intellia Therapeutics' Non Operating Investment Income fell 22.75% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$429,000, marking a year-over-year increase of 97.85%. This contributed to the annual value of -$32.6 million for FY2024, which is 995.87% down from last year.
  • According to the latest figures from Q3 2025, Intellia Therapeutics' Non Operating Investment Income is $3.4 million, which was up 156.83% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Intellia Therapeutics' Non Operating Investment Income registered a high of $4.5 million during Q3 2024, and its lowest value of -$20.4 million during Q2 2024.
  • Over the past 3 years, Intellia Therapeutics' median Non Operating Investment Income value was $142,000 (recorded in 2023), while the average stood at -$1.7 million.
  • Per our database at Business Quant, Intellia Therapeutics' Non Operating Investment Income tumbled by 93,100.00% in 2022 and then spiked by 3,035.21% in 2024.
  • Quarterly analysis of 5 years shows Intellia Therapeutics' Non Operating Investment Income stood at -$2.0 million in 2021, then skyrocketed by 275.91% to $3.4 million in 2022, then tumbled by 42.13% to $2.0 million in 2023, then slumped by 255.19% to -$3.1 million in 2024, then decreased by 22.75% to $3.4 million in 2025.
  • Its Non Operating Investment Income was $3.4 million in Q3 2025, compared to $1.3 million in Q2 2025 and -$2.1 million in Q1 2025.